UNITED CANNABIS CORPORATION (OTCMKTS:CNAB) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
ITEM 5.02
DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF
DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY
ARRANGEMENTS OF CERTAIN OFFICERS.
On May 31, 2017, the Company adopted the 2017 Stock Incentive
Plan (the 2017 Plan). to the 2017 Plan, awards may be in the form
of Incentive Stock Options, Non-Qualified Stock Options, or Stock
Bonuses. Up to 6,000,000 shares of common stock can be issued to
the 2017 Plan upon the exercise of options granted to the 2017
Plan or for shares awarded as stock bonuses.
On May 31, 2017 the Company granted Non-Qualified Stock Options
to the persons, in the amounts, and upon the terms shown below:
|
Shares Issuable Upon |
Option |
Expiration |
||||
|
Name |
Exercise of Option |
Exercise Price |
Date |
|||
|
|
||||||
|
Earnest Blackmon |
100,000 |
|
$0.56 |
May 30, 2027 |
||
|
Tony Verzura |
100,000 |
|
$0.56 |
May 30, 2027 |
||
|
Chadwick Ruby |
2,600,000 |
|
$0.56 |
May 30, 2027 |
About UNITED CANNABIS CORPORATION (OTCMKTS:CNAB)
United Cannabis Corporation is engaged in medical spa management business. The Company focuses on providing products, services and intellectual property to the cannabis industry. It owns intellectual property relating to the legalized growth, production, manufacture, marketing, management, utilization and distribution of medical and recreational marijuana and marijuana infused products. The Company focuses on advancing the use of phytocannabinoid therapeutics in medicine through research, product development and education. The Company’s ACT Now Program utilizes its Prana Bio Nutrient Medicinals with a Health Insurance Portability and Accountability Act (HIPAA) of 1996 compliant electronic health record (EHR) software that enables physicians to create sequencing charts specific to their patients’ medical aliments. The ACT Now EHR software allows for global monitoring, patient management and cannabinoid therapy protocols. It offers consulting and training services.
